Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 2
2015 2
2016 1
2017 2
2018 2
2019 11
2020 8
2021 6
2022 15
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
Chandra A, Lewis EF, Claggett BL, Desai AS, Packer M, Zile MR, Swedberg K, Rouleau JL, Shi VC, Lefkowitz MP, Katova T, McMurray JJV, Solomon SD. Chandra A, et al. JAMA Cardiol. 2018 Jun 1;3(6):498-505. doi: 10.1001/jamacardio.2018.0398. JAMA Cardiol. 2018. PMID: 29617523 Free PMC article. Clinical Trial.
Cardio-oncology imaging tools at the translational interface.
Yaros K, Eksi B, Chandra A, Agusala K, Lehmann LH, Zaha VG. Yaros K, et al. Among authors: chandra a. J Mol Cell Cardiol. 2022 Jul;168:24-32. doi: 10.1016/j.yjmcc.2022.03.012. Epub 2022 Apr 3. J Mol Cell Cardiol. 2022. PMID: 35385715 Review.
Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Chandra A, Vaduganathan M, Lewis EF, Claggett BL, Rizkala AR, Wang W, Lefkowitz MP, Shi VC, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV, Solomon SD; PARAGON-HF Investigators. Chandra A, et al. JACC Heart Fail. 2019 Oct;7(10):862-874. doi: 10.1016/j.jchf.2019.05.015. Epub 2019 Jul 10. JACC Heart Fail. 2019. PMID: 31302043 Free article.
Cardiovascular disease and chimeric antigen receptor cellular therapy.
Rao A, Stewart A, Eljalby M, Ramakrishnan P, Anderson LD Jr, Awan FT, Chandra A, Vallabhaneni S, Zhang K, Zaha VG. Rao A, et al. Among authors: chandra a. Front Cardiovasc Med. 2022 Sep 23;9:932347. doi: 10.3389/fcvm.2022.932347. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36211558 Free PMC article. Review.
Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis.
Segar MW, Jaeger BC, Patel KV, Nambi V, Ndumele CE, Correa A, Butler J, Chandra A, Ayers C, Rao S, Lewis AA, Raffield LM, Rodriguez CJ, Michos ED, Ballantyne CM, Hall ME, Mentz RJ, de Lemos JA, Pandey A. Segar MW, et al. Among authors: chandra a. Circulation. 2021 Jun 15;143(24):2370-2383. doi: 10.1161/CIRCULATIONAHA.120.053134. Epub 2021 Apr 13. Circulation. 2021. PMID: 33845593 Free article.
Health-related quality of life outcomes in PARAGON-HF.
Chandra A, Polanczyk CA, Claggett BL, Vaduganathan M, Packer M, Lefkowitz MP, Rouleau JL, Liu J, Shi VC, Schwende H, Zile MR, Desai AS, Pfeffer MA, McMurray JJV, Solomon SD, Lewis EF. Chandra A, et al. Eur J Heart Fail. 2022 Dec;24(12):2264-2274. doi: 10.1002/ejhf.2738. Epub 2022 Dec 9. Eur J Heart Fail. 2022. PMID: 36394533 Clinical Trial.
46 results